Rodriquenz, M.G.; Roviello, G.; D’Angelo, A.; Lavacchi, D.; Roviello, F.; Polom, K.
MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy. J. Clin. Med. 2020, 9, 1427.
https://doi.org/10.3390/jcm9051427
AMA Style
Rodriquenz MG, Roviello G, D’Angelo A, Lavacchi D, Roviello F, Polom K.
MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy. Journal of Clinical Medicine. 2020; 9(5):1427.
https://doi.org/10.3390/jcm9051427
Chicago/Turabian Style
Rodriquenz, Maria Grazia, Giandomenico Roviello, Alberto D’Angelo, Daniele Lavacchi, Franco Roviello, and Karol Polom.
2020. "MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy" Journal of Clinical Medicine 9, no. 5: 1427.
https://doi.org/10.3390/jcm9051427
APA Style
Rodriquenz, M. G., Roviello, G., D’Angelo, A., Lavacchi, D., Roviello, F., & Polom, K.
(2020). MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy. Journal of Clinical Medicine, 9(5), 1427.
https://doi.org/10.3390/jcm9051427